Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage

39Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

To investigate the neuroprotective effect of brimonidine after retinal ischemia damage on mouse eye. Glaucoma is an optic neuropathy characterized by retinal ganglion cells (RGCs) death, irreversible peripheral and central visual field loss, and high intraocular pressure. Ischemia reperfusion (I/R) injury model was used in C57BL/6J mice to mimic conditions of glaucomatous neurodegeneration. Mouse eyes were treated topically with brimonidine and pattern electroretinogram were used to assess the retinal ganglion cells (RGCs) function. A wide range of inflammatory markers, as well as anti-inflammatory and neurotrophic molecules, were investigated to figure out the potential protective effects of brimonidine in mouse retina. In particular, brain-derived neurotrophic factor (BDNF), IL-6, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor DR-5, TNF-α, GFAP, Iba-1, NOS, IL-1β and IL-10 were assessed in mouse retina that underwent to I/R insult with or without brimonidine treatment. Brimonidine provided remarkable RGCs protection in our paradigm. PERG amplitude values were significantly (p < 0.05) higher in brimonidine-treated eyes in comparison to I/R retinas. Retinal BDNF mRNA levels in the I/R group dropped significantly (p < 0.05) compared to the control group (normal mice); brimonidine treatment counteracted the downregulation of retinal BDNF mRNA in I/R eyes. Retinal inflammatory markers increased significantly (p < 0.05) in the I/R group and brimonidine treatment was able to revert that. The anti-inflammatory IL-10 decreased significantly (p < 0.05) after retinal I/R insult and increased significantly (p < 0.05) in the group treated with brimonidine. In conclusion, brimonidine was effective in preventing loss of function of RGCs and in regulating inflammatory biomarkers elicited by retinal I/R injury.

References Powered by Scopus

Retinal ischemia: Mechanisms of damage and potential therapeutic strategies

926Citations
N/AReaders
Get full text

Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells

718Citations
N/AReaders
Get full text

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

635Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Ocular neurodegenerative diseases: Interconnection between retina and cortical areas

78Citations
N/AReaders
Get full text

Role of oxidative stress in ocular diseases associated with retinal ganglion cells degeneration

57Citations
N/AReaders
Get full text

Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies

39Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Conti, F., Romano, G. L., Eandi, C. M., Toro, M. D., Rejdak, R., Di Benedetto, G., … Bucolo, C. (2021). Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.705405

Readers over time

‘21‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

36%

Researcher 4

36%

Professor / Associate Prof. 3

27%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

40%

Neuroscience 3

30%

Agricultural and Biological Sciences 2

20%

Pharmacology, Toxicology and Pharmaceut... 1

10%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 21

Save time finding and organizing research with Mendeley

Sign up for free
0